Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation
Citations Over TimeTop 10% of 2008 papers
Abstract
Liver transplantation (LT) is the only therapeutic option for end-stage primary sclerosing cholangitis (PSC), but PSC can recur (rPSC) in some patients after LT. The aim of our study was to evaluate the risk factors associated with rPSC. Between 1989 and 2004, 69 patients receiving transplantation for PSC (42 male, mean age 41.9 yr). Clinical and laboratory data, activity/extension and treatment of ulcerative colitis (UC), post-LT cytomegalovirus (CMV) infection, and immunosuppression were evaluated. Determination of rPSC was made by radiological and histological findings. Exclusion criteria were ABO blood group incompatibility, hepatic artery stenosis, and biliary strictures occurring in 3 months) post-LT was the only risk factor significantly associated with rPSC (P = 0.025). In conclusion, the presence of UC post-LT, and the need for maintenance steroids post-LT, which is an independent factor, are associated with rPSC. These findings could help elucidate a possible mechanism of PSC pathogenesis.
Related Papers
- → Neutrophil autoantibodies: A genetic marker in primary sclerosing cholangitis and ulcerative colitis(1994)171 cited
- → HLA antigens in ulcerative colitis and primary sclerosing cholangitis(1995)38 cited
- → Immunosuppression after pediatric liver transplant: The parents’ perspective(2023)3 cited
- → Liver transplantation for primary sclerosing cholangitis(1999)15 cited
- Determination of plasma P-selection in patients with ulcerative colitis and their clinical significance(2004)